Analyst consensus rating
Amneal Pharmaceuticals Analyst Rating: Strong Buy
Direct answer
Amneal Pharmaceuticals's consensus rating is Strong Buy.
7 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $24.29.
Forecast evidence checked November 12, 2026.
Get free Amneal Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $21.71
- Average price target
- $24.29
- High price target
- $28.00
- Low price target
- $20.00
- Low target gap
- -7.9%
- Target upside
- +11.9%
- High target gap
- +29%
- Target range width
- 36.8%
- Consensus rating
- Strong Buy
- Analysts
- 7
- Evidence date
- November 12, 2026
- Valid through
- November 19, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Amneal Pharmaceuticals?
Amneal Pharmaceuticals has a verified Strong Buy consensus. The same dataset has an average price target of $24.29.
How far are Amneal Pharmaceuticals's low and high targets from the recorded price?
The low target implies -7.9%, while the high target implies +29%.
How many analysts are included in Amneal Pharmaceuticals's consensus?
The verified consensus includes 7 analysts.
How is Amneal Pharmaceuticals's target upside or downside calculated?
The average target of $24.29 is divided by the recorded price of $21.71, then one is subtracted to produce +11.9%. This does not guarantee a future return.
When was Amneal Pharmaceuticals's analyst forecast verified?
The data was verified on 2026-11-12. The dataset is valid through 2026-11-19.